Homocysteinemia, hypertension, and family history of diabetes in a smoking male population in Saudi Arabia

Central European Journal of Medicine

Volumn 3, Issue 2, 2008, Pages 167-172

  Al Daghri, Nasser M ^a   Al Attas, Omar S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Family history of diabetes; Homocysteine; Lipids, Blood pressure; Saudi Arabia; Smoking

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AGED; ARAB; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ELECTROCHEMICAL ANALYSIS; FAMILY HISTORY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SAUDI ARABIA; SMOKING; VITAMIN SUPPLEMENTATION;

EID: 41949098254     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-008-0019-9     Document Type: Article

References (35)

1. Bleie O., Semb A.G., Grundt H., Nordrehauq J.E., Vollset S.E., Ueland P.M., et al., Homocysteinelowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease, J. Intern. Med., 2007, 262, 244-253
2. Wierzbicki A.S., Homocysteine and cardiovascular disease: a review of evidence, Diab. Vasc. Dis. Res., 2007, 4, 143-150
3. Signorello M.G., Viviani G.L., Armani U., Cerone R., Minniti G., Piana A. et al., Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus, Thromb. Res., 2007, 120, 607-613
4. Zakai N.A., Katz R., Jenny N.S., Psaty B.M., Reiner A.P., Schwartz S.M., et al., Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study, J. Thromb. Haemost., 2007, 5, 1125-1127
5. Gonzales S., Huerta J.M., Fernandez S., Patterson A.M., Laceras C., Homocysteine increases the risk of mortality in elderly individuals, Br. J. Nutr., 2007, 97, 1128-1135
6. Kennedy B.P., Faraq N.H., Ziegler M.G., Mills P.J., Relationship of systolic blood pressure with plasma homocysteine: importance of smoking status, J. Hypertens., 2003, 21, 1307-1312
7. Pernod G., Bosson J.L., Golshayan D., Barro C., Alloatti S., Turc-Baron C., et al., Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients, J. Nephrol., 2004, 17, 66-75
8. Retterstol L., Paus B., Bohn M., Bakken A., Erikssen J., Malinow M.R., Berq K., Plasma total homocysteine levels and prognosis in patients with previous premature myocardial infarction: a 10-year follow-up study, J. Intern. Med., 2003, 253, 284-292
9. Castelli W.P., Epidemiology of coronary heart disease: the Framingham study, Am. J. Med., 1984, 76, 4-12
10. Reis R.P., Azinheira J., Reis H.P., Pina J.E., Correia J.M., Luis A.S., Influence of smoking on homocysteinemia at baseline and alter methionine load, Rev. Port. Cardiol., 2000, 19, 471-474
11. Sharper A.G., Pocock S.J., Walker M., Phillips A.N., Whitehead T.P., MacFarlane T.W., Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study, J. Epidemiol. Community Health, 1985, 39, 197-209
12. Jarallah J.S., Al-Rubeaan K.A., Al-Nuaim A.R., Al-Ruhaily A.A., Kalantan K.A., Prevalence and determinants of smoking in three regions of Saudi Arabia, Tob. Control., 1999, 8, 53-56
13. Heidrich J., Wellman J., Heuschmann P.U., Kraywinkel K., Keil U., Mortality and morbidity from coronary heart disease attributable to smoking, Eur. Heart J., 2007, 20, 2498-502
14. Leone A., Smoking, haemostatic factors and cardiovascular risk, Curr. Pharm. Des., 2007, 13, 1661-1667
15. O'Callaghan P., Meleady R., Fitzgerald T., Graham I., European COMAC Group, Smoking and plasma homocysteine, Eur. Heart J., 2002, 23, 1580-1586
16. Al-Nozha M.M., Arafah M.R., Al-Mazrou Y.Y., Al-Maatouq M.A., Khan N.B., Khalil M.Z., et. al., Coronary artery disease in Saudi Arabia. Saudi Med. J., 2004, 25, 1165-1171
17. Pagan K., Hou J., Goldenberg R.L., Cliver S.P., Tamura T., Effect of smoking on serum concentrations of total homocysteine and B vitamins in mid-pregnancy, Clin. Chim. Acta., 2001, 306, 103-109
18. Mc Carty M.F., Increased homocyst(e)ine associated with smoking, chronic inflammation, and aging may reflect acute phase induction of pyridoxal phosphatase activity, Med. Hypotheses, 2000, 55, 289-293
19. Fanapour P.C., Yug B., Kocharn M.S., Hyperhomocysteinemia: an additional cardiovascular risk factor, W.M.J., 1999, 98, 51-54
20. Giannetti N., Herity N.A., Alimollah A., Gao S.Z., Schroeder J.S., Yeung A.C., et al., Mild Hyperhomocysteinemia is not associated with cardiac allograft coronary disease, Clin. Transplant, 2001, 15, 247-252
21. Lee B.J., Lin P.T., Liaw Y.P., Chang S.J., Cheng C.H., Huang Y.C., Homocysteine and risk of coronary artery disease: Folate is the important determinant of plasma homocysteine concentration, Nutrition, 2003, 19, 577-583
22. Gazi I.F., Elisaf M., LDL-cholesterol calculation formulas in patients with or without metabolic syndrome, Int. J. Cardiol., 2007, 119, 414-415
23. Martin S.C., Tsakas-Ampatzis I., Bartlett W.A., Jones A.F., Measurement of plasma homocysteine by HPLC with coulometric detection, Clin. Chem., 1999, 45, 150-152
24. Lip G.Y., Edmunds E., Martin S.C., Jones A.F., Blann A.D., Beevers D.G., A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage, Am. J. Hypertens., 2001, 14, 627-631
25. Tayama J., Munakata M., Yoshinaga K., Toyota T., Higher plasma homocysteine concentration is associated with more advanced systemic arterial stiffness and greater blood pressure response to stress in hypertensive patients, Hypertens. Res., 2006, 29, 403-409
26. Boers G.H., Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease, Semin. Thromb. Hemost., 2000, 26, 291-295
27. Rodrigo R., Passalacqua W., Arraya J., Orellana M., Rivera G., Homocysteine and essential hipertensión, J. Clin. Pharmacol., 2003, 43, 1299-1306
28. Sundstrom J., Sullivan L., D'Agostino R.B., Jacques P.F., Selhub J., Rosenberg R.H. et. al., Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart Study, Hypertension, 2003, 42, 1100-1105
29. Stein J.H., Bushara M., Bushara K., McBride P.E., Jorenby D.E., Fiore M.C., Smoking cessation, but not smoking reduction, reduces plasma homocysteine levels, Clin. Cardiol., 2002, 25, 23-26
30. Tonstad S., Urdal P., Does short-term smoking cessation reduce plasma total homocysteine concentrations? Scand. J. Clin. Lab. Invest, 2002, 62, 279-284
31. Abu-Amero K.K., Wyngaard C.A., Dzimiri N., Prevalence and role of methylenetetrahydrofolate 677C-T and 1298A-C polymorphism in coronary artery disease in Arabs, Arch. Pathol. Lab. Med., 2003, 127, 1349-1352
32. Bu R., Gutierrez M.I., Al-Rasheed M., Belgaumi A., Bhatia K., Variable drug metabolism genes in Arab population, Pharmacogenomics, 2004, 4, 260-266
33. Blum A., Hijazi I., Eizenberg M.M., Blum N., Homocysteine (Hcy) follow-up, Clin. Invest Med., 2007, 30, 21-25
34. Liao D., Tan H., Hui R., Li Z., Jiang X., Gaubatz J. et al., Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A1 protein synthesis and enhancing HDL cholesterol clearance, Circ. Res., 2006, 99, 565-566
35. Al-Nozha M., Al-Daghri N., Bartlett W.A., Al-Attas O., Al-Maatouq M., Martin S.C., et al., Serum homocysteine concentration is related to diabetes mellitus, but not to coronary heart disease in Saudi Arabians, Diabetes Obes. Metab., 2002, 4, 118-123